Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Oct;74(2):445–454. doi: 10.1111/j.1476-5381.1981.tb09990.x

The effects of piperazine on rat sympathetic neurones.

J D Connor, A Constanti, P M Dunn, A Forward, A Nistri
PMCID: PMC2071726  PMID: 7317692

Abstract

1. The neuronal effects of the anthelmintic piperazine (Pip) on rat sympathetic ganglia were studied in vitro by means of intracellular and extracellular recording techniques. 2. Surface potential recordings indicated that Pip (0.1-10 mM as citrate, 1-30 mM as hexahydrate) produced a sustained depolarization (reversible on washing) of rat ganglia. gamma-Aminobutyric acid (GABA, 1-100 micro M) also evoked reversible depolarizations but, unlike Pip, responses to the higher doses of GABA declined during a 2 min exposure. Depolarizations produced by Pip or carbachol (but not GABA) were markedly depressed by hexamethonium but only slightly by bicuculline or picrotoxin. 3. Intracellular recordings revealed that Pip-induced depolarizations were accompanied by an increase in membrane conductance and a broadening and depression of the directly-evoked spike. 4. In the presence of hexamethonium (1 mM), the responses to Pip hexahydrate and to cholinoceptor agonists were abolished, but Pip citrate still changed the spike configuration and induced membrane hyperpolarization with a small conductance increase. These residual effects were mimicked by superfusing with Na citrate or Ca2+-free medium, suggesting that significant Ca2+ binding by the citrate anion of the Pip salt was probably responsible for the observed activity of Pip citrate in the presence of hexamethonium. 5. It is concluded that on rat ganglia Pip is a nicotinic agonist, with no detectable GABA-mimetic activity.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams P. R., Brown D. A. Actions of gamma-aminobutyric acid on sympathetic ganglion cells. J Physiol. 1975 Aug;250(1):85–120. doi: 10.1113/jphysiol.1975.sp011044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belloni C., Rizzoni G. Neurotoxic side-effects of piperazine. Lancet. 1967 Aug 12;2(7511):369–369. doi: 10.1016/s0140-6736(67)90205-x. [DOI] [PubMed] [Google Scholar]
  3. Berger J. R., Globus M., Melamed E. Acute transitory cerebellar dysfunction associated with piperazine adipate. Arch Neurol. 1979 Mar;36(3):180–181. doi: 10.1001/archneur.1979.00500390098019. [DOI] [PubMed] [Google Scholar]
  4. Bomb B. S., Bedi H. K. Neurotoxic side-effects of piperazine. Trans R Soc Trop Med Hyg. 1976;70(4):358–358. doi: 10.1016/0035-9203(76)90108-5. [DOI] [PubMed] [Google Scholar]
  5. Bowery N. G., Brown D. A. Depolarizing actions of gamma-aminobutyric acid and related compounds on rat superior cervical ganglia in vitro. Br J Pharmacol. 1974 Feb;50(2):205–218. doi: 10.1111/j.1476-5381.1974.tb08563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown D. A., Constanti A. Intracellular observations on the effects of muscarinic agonists on rat sympathetic neurones. Br J Pharmacol. 1980 Dec;70(4):593–608. doi: 10.1111/j.1476-5381.1980.tb09778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown D. A., Fatherazi S., Garthwaite J., White R. D. Muscarinic receptors in rat sympathetic ganglia. Br J Pharmacol. 1980 Dec;70(4):577–592. doi: 10.1111/j.1476-5381.1980.tb09777.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brown D. A., Marsh S. A very simple method for recording ganglion depolarization. J Physiol. 1975 Mar;246(2):24P–26P. [PubMed] [Google Scholar]
  9. Constanti A., Nistri A. A comparative study of the action of gamma-aminobutyric acid and piperazine on the lobster muscle fibre and the frog spinal cord. Br J Pharmacol. 1976 Jul;57(3):347–358. doi: 10.1111/j.1476-5381.1976.tb07673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Desowitz R. S. Antiparasite chemotherapy. Annu Rev Pharmacol. 1971;11:351–368. doi: 10.1146/annurev.pa.11.040171.002031. [DOI] [PubMed] [Google Scholar]
  11. FRANKENHAEUSER B., HODGKIN A. L. The action of calcium on the electrical properties of squid axons. J Physiol. 1957 Jul 11;137(2):218–244. doi: 10.1113/jphysiol.1957.sp005808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gupta S. R. Piperazine neurotoxicity and psychological reaction. J Indian Med Assoc. 1976 Jan 16;66(2):33–34. [PubMed] [Google Scholar]
  13. Hanna S., Tang A. Human urinary excretion of piperazine citrate from syrup formulations. J Pharm Sci. 1973 Dec;62(12):2024–2025. doi: 10.1002/jps.2600621227. [DOI] [PubMed] [Google Scholar]
  14. Iravani J. Wechselbeziehung von Barbituraten und Piperazin mit GABA an der Membran des Krebsmuskels. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1965 Jul 26;251(3):265–274. [PubMed] [Google Scholar]
  15. Jenkinson D. H., Terrar D. A. Influence of chloride ions on changes in membrane potential during prolonged application of carbachol to frog skeletal muscle. Br J Pharmacol. 1973 Feb;47(2):363–376. doi: 10.1111/j.1476-5381.1973.tb08334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kasé Y., Miyata T., Kamikawa Y., Kataoka M. Pharmacological studies on alicyclic amines. (II). Central actions of piperidine, pyrrolidine and piperazine. Jpn J Pharmacol. 1969 Jun;19(2):300–314. [PubMed] [Google Scholar]
  17. Kasé Y., Miyata T., Yuizono T. Pharmacological studies on alicyclic amines. I. Comparison of pharmacological activities of piperidine with those of other amines. Jpn J Pharmacol. 1967 Sep;17(3):475–490. doi: 10.1254/jjp.17.475. [DOI] [PubMed] [Google Scholar]
  18. Katz M. Anthelmintics. Drugs. 1977 Feb;13(2):124–136. doi: 10.2165/00003495-197713020-00002. [DOI] [PubMed] [Google Scholar]
  19. Krnjević K., Lamour Y., MacDonald J. F., Nistri A. Effects of some divalent cations on motoneurones in cats. Can J Physiol Pharmacol. 1979 Sep;57(9):944–956. doi: 10.1139/y79-144. [DOI] [PubMed] [Google Scholar]
  20. Marder E., Paupardin-Tritsch D. Picrotoxin block of a depolarizing ACh response. Brain Res. 1980 Jan 6;181(1):223–227. doi: 10.1016/0006-8993(80)91275-5. [DOI] [PubMed] [Google Scholar]
  21. McAfee D. A., Yarowsky P. J. Calcium-dependent potentials in the mammalian sympathetic neurone. J Physiol. 1979 May;290(2):507–523. doi: 10.1113/jphysiol.1979.sp012787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller C. G., Carpenter R. Neurotoxic side-effects of piperazine. Lancet. 1967 Apr 22;1(7495):895–896. doi: 10.1016/s0140-6736(67)91453-5. [DOI] [PubMed] [Google Scholar]
  23. Most H. Treatment of common parasitic infections of man encountered in the United States. I. N Engl J Med. 1972 Sep 7;287(10):495–498. doi: 10.1056/NEJM197209072871006. [DOI] [PubMed] [Google Scholar]
  24. NORTON S., DE BEER E. J. Investigations on the action of piperazine on Ascaris lumbricoides. Am J Trop Med Hyg. 1957 Sep;6(5):898–905. doi: 10.4269/ajtmh.1957.6.898. [DOI] [PubMed] [Google Scholar]
  25. Nistri A., Arenson M. S. Effect of piperazine on central and peripheral cholinergic synapses of the frog. Experientia. 1978 Aug 15;34(8):1046–1047. doi: 10.1007/BF01915338. [DOI] [PubMed] [Google Scholar]
  26. Nistri A., Constanti A. Pharmacological characterization of different types of GABA and glutamate receptors in vertebrates and invertebrates. Prog Neurobiol. 1979;13(2):117–235. doi: 10.1016/0301-0082(79)90016-9. [DOI] [PubMed] [Google Scholar]
  27. Parsons A. C. Piperazine neurotoxicity: "worm wobble". Br Med J. 1971 Dec 25;4(5790):792–792. doi: 10.1136/bmj.4.5790.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rang H. P. The kinetics of action of acetylcholine antagonists in smooth muscle. Proc R Soc Lond B Biol Sci. 1966 Apr 19;164(996):488–510. doi: 10.1098/rspb.1966.0045. [DOI] [PubMed] [Google Scholar]
  29. Sheth U. K. Mechanisms of anthelmintic action. Prog Drug Res. 1975;19:147–157. doi: 10.1007/978-3-0348-7090-0_19. [DOI] [PubMed] [Google Scholar]
  30. Shinozaki H., Konishi S. Actions of several anthelmintics and insecticides on rat cortical neurones. Brain Res. 1970 Dec 1;24(2):368–371. doi: 10.1016/0006-8993(70)90122-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES